United States Influenza Medication Industry 2017 Market Research Report

 Table of Contents

United States Influenza Medication Market Report 2017
1 Influenza Medication Overview
    1.1 Product Overview and Scope of Influenza Medication
    1.2 Classification of Influenza Medication by Product Category
        1.2.1 United States Influenza Medication Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Influenza Medication Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Typical Influenza Medication
        1.2.4 Light Influenza Medication
        1.2.5 Pneumonia Influenza Medication
    1.3 United States Influenza Medication Market by Application/End Users
        1.3.1 United States Influenza Medication Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Pharmacy
        1.3.5 Other
    1.4 United States Influenza Medication Market by Region
        1.4.1 United States Influenza Medication Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Influenza Medication Status and Prospect (2012-2022)
        1.4.3 Southwest Influenza Medication Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Influenza Medication Status and Prospect (2012-2022)
        1.4.5 New England Influenza Medication Status and Prospect (2012-2022)
        1.4.6 The South Influenza Medication Status and Prospect (2012-2022)
        1.4.7 The Midwest Influenza Medication Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Influenza Medication (2012-2022)
        1.5.1 United States Influenza Medication Sales and Growth Rate (2012-2022)
        1.5.2 United States Influenza Medication Revenue and Growth Rate (2012-2022)

2 United States Influenza Medication Market Competition by Players/Suppliers
    2.1 United States Influenza Medication Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Influenza Medication Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Influenza Medication Average Price by Players/Suppliers (2012-2017)
    2.4 United States Influenza Medication Market Competitive Situation and Trends
        2.4.1 United States Influenza Medication Market Concentration Rate
        2.4.2 United States Influenza Medication Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Influenza Medication Manufacturing Base Distribution, Sales Area, Product Type

3 United States Influenza Medication Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Influenza Medication Sales and Market Share by Region (2012-2017)
    3.2 United States Influenza Medication Revenue and Market Share by Region (2012-2017)
    3.3 United States Influenza Medication Price by Region (2012-2017)

4 United States Influenza Medication Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Influenza Medication Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Influenza Medication Revenue and Market Share by Type (2012-2017)
    4.3 United States Influenza Medication Price by Type (2012-2017)
    4.4 United States Influenza Medication Sales Growth Rate by Type (2012-2017)

5 United States Influenza Medication Sales (Volume) by Application (2012-2017)
    5.1 United States Influenza Medication Sales and Market Share by Application (2012-2017)
    5.2 United States Influenza Medication Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Influenza Medication Players/Suppliers Profiles and Sales Data
    6.1 Bristol-Myers Squibb
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Influenza Medication Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bristol-Myers Squibb Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 AstraZeneca
        6.2.2 Influenza Medication Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 AstraZeneca Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eli Lilly
        6.3.2 Influenza Medication Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eli Lilly Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Roche
        6.4.2 Influenza Medication Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Roche Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 GSK
        6.5.2 Influenza Medication Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GSK Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Novartis
        6.6.2 Influenza Medication Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Pfizer
        6.7.2 Influenza Medication Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Pfizer Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Sanofi
        6.8.2 Influenza Medication Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Sanofi Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Bayer
        6.9.2 Influenza Medication Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Bayer Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Celgene
        6.10.2 Influenza Medication Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Celgene Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Influenza Medication Manufacturing Cost Analysis
    7.1 Influenza Medication Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Influenza Medication

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Influenza Medication Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Influenza Medication Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Influenza Medication Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Influenza Medication Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Influenza Medication Sales Volume Forecast by Type (2017-2022)
    11.3 United States Influenza Medication Sales Volume Forecast by Application (2017-2022)
    11.4 United States Influenza Medication Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Influenza Medication
    Figure United States Influenza Medication Market Size (K Pcs) by Type (2012-2022)
    Figure United States Influenza Medication Sales Volume Market Share by Type (Product Category) in 2016
    Figure Typical Influenza Medication Product Picture
    Figure Light Influenza Medication Product Picture
    Figure Pneumonia Influenza Medication Product Picture
    Figure United States Influenza Medication Market Size (K Pcs) by Application (2012-2022)
    Figure United States Sales Market Share of Influenza Medication by Application in 2016
    Figure Hospital Examples
    Figure Clinic Examples
    Figure Pharmacy Examples
    Figure Other Examples
    Figure United States Influenza Medication Market Size (Million USD) by Region (2012-2022)
    Figure The West Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southwest Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Middle Atlantic Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
    Figure New England Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The South of US Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Midwest Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Influenza Medication Sales (K Pcs) and Growth Rate (2012-2022)
    Figure United States Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Influenza Medication Market Major Players Product Sales Volume (K Pcs) (2012-2017)
    Table United States Influenza Medication Sales (K Pcs) of Key Players/Suppliers (2012-2017)
    Table United States Influenza Medication Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Influenza Medication Sales Share by Players/Suppliers
    Figure 2017 United States Influenza Medication Sales Share by Players/Suppliers
    Figure United States Influenza Medication Market Major Players Product Revenue (Million USD) (2012-2017)
    Table United States Influenza Medication Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table United States Influenza Medication Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Influenza Medication Revenue Share by Players/Suppliers
    Figure 2017 United States Influenza Medication Revenue Share by Players/Suppliers
    Table United States Market Influenza Medication Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
    Figure United States Market Influenza Medication Average Price (USD/Pcs) of Key Players/Suppliers in 2016
    Figure United States Influenza Medication Market Share of Top 3 Players/Suppliers
    Figure United States Influenza Medication Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Influenza Medication Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Influenza Medication Product Category
    Table United States Influenza Medication Sales (K Pcs) by Region (2012-2017)
    Table United States Influenza Medication Sales Share by Region (2012-2017)
    Figure United States Influenza Medication Sales Share by Region (2012-2017)
    Figure United States Influenza Medication Sales Market Share by Region in 2016
    Table United States Influenza Medication Revenue (Million USD) and Market Share by Region (2012-2017)
    Table United States Influenza Medication Revenue Share by Region (2012-2017)
    Figure United States Influenza Medication Revenue Market Share by Region (2012-2017)
    Figure United States Influenza Medication Revenue Market Share by Region in 2016
    Table United States Influenza Medication Price (USD/Pcs) by Region (2012-2017)
    Table United States Influenza Medication Sales (K Pcs) by Type (2012-2017)
    Table United States Influenza Medication Sales Share by Type (2012-2017)
    Figure United States Influenza Medication Sales Share by Type (2012-2017)
    Figure United States Influenza Medication Sales Market Share by Type in 2016
    Table United States Influenza Medication Revenue  (Million USD) and Market Share by Type (2012-2017)
    Table United States Influenza Medication Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Influenza Medication by Type (2012-2017)
    Figure Revenue Market Share of Influenza Medication by Type in 2016
    Table United States Influenza Medication Price (USD/Pcs) by Types (2012-2017)
    Figure United States Influenza Medication Sales Growth Rate by Type (2012-2017)
    Table United States Influenza Medication Sales (K Pcs) by Application (2012-2017)
    Table United States Influenza Medication Sales Market Share by Application (2012-2017)
    Figure United States Influenza Medication Sales Market Share by Application (2012-2017)
    Figure United States Influenza Medication Sales Market Share by Application in 2016
    Table United States Influenza Medication Sales Growth Rate by Application (2012-2017)
    Figure United States Influenza Medication Sales Growth Rate by Application (2012-2017)
    Table Bristol-Myers Squibb Basic Information List
    Table Bristol-Myers Squibb Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Bristol-Myers Squibb Influenza Medication Sales Growth Rate (2012-2017)
    Figure Bristol-Myers Squibb Influenza Medication Sales Market Share in United States (2012-2017)
    Figure Bristol-Myers Squibb Influenza Medication Revenue Market Share in United States (2012-2017)
    Table AstraZeneca Basic Information List
    Table AstraZeneca Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure AstraZeneca Influenza Medication Sales Growth Rate (2012-2017)
    Figure AstraZeneca Influenza Medication Sales Market Share in United States (2012-2017)
    Figure AstraZeneca Influenza Medication Revenue Market Share in United States (2012-2017)
    Table Eli Lilly Basic Information List
    Table Eli Lilly Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Eli Lilly Influenza Medication Sales Growth Rate (2012-2017)
    Figure Eli Lilly Influenza Medication Sales Market Share in United States (2012-2017)
    Figure Eli Lilly Influenza Medication Revenue Market Share in United States (2012-2017)
    Table Roche Basic Information List
    Table Roche Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Roche Influenza Medication Sales Growth Rate (2012-2017)
    Figure Roche Influenza Medication Sales Market Share in United States (2012-2017)
    Figure Roche Influenza Medication Revenue Market Share in United States (2012-2017)
    Table GSK Basic Information List
    Table GSK Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure GSK Influenza Medication Sales Growth Rate (2012-2017)
    Figure GSK Influenza Medication Sales Market Share in United States (2012-2017)
    Figure GSK Influenza Medication Revenue Market Share in United States (2012-2017)
    Table Novartis Basic Information List
    Table Novartis Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Novartis Influenza Medication Sales Growth Rate (2012-2017)
    Figure Novartis Influenza Medication Sales Market Share in United States (2012-2017)
    Figure Novartis Influenza Medication Revenue Market Share in United States (2012-2017)
    Table Pfizer Basic Information List
    Table Pfizer Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Pfizer Influenza Medication Sales Growth Rate (2012-2017)
    Figure Pfizer Influenza Medication Sales Market Share in United States (2012-2017)
    Figure Pfizer Influenza Medication Revenue Market Share in United States (2012-2017)
    Table Sanofi Basic Information List
    Table Sanofi Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Sanofi Influenza Medication Sales Growth Rate (2012-2017)
    Figure Sanofi Influenza Medication Sales Market Share in United States (2012-2017)
    Figure Sanofi Influenza Medication Revenue Market Share in United States (2012-2017)
    Table Bayer Basic Information List
    Table Bayer Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Bayer Influenza Medication Sales Growth Rate (2012-2017)
    Figure Bayer Influenza Medication Sales Market Share in United States (2012-2017)
    Figure Bayer Influenza Medication Revenue Market Share in United States (2012-2017)
    Table Celgene Basic Information List
    Table Celgene Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Celgene Influenza Medication Sales Growth Rate (2012-2017)
    Figure Celgene Influenza Medication Sales Market Share in United States (2012-2017)
    Figure Celgene Influenza Medication Revenue Market Share in United States (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Influenza Medication
    Figure Manufacturing Process Analysis of Influenza Medication
    Figure Influenza Medication Industrial Chain Analysis
    Table Raw Materials Sources of Influenza Medication Major Players/Suppliers in 2016
    Table Major Buyers of Influenza Medication
    Table Distributors/Traders List
    Figure United States Influenza Medication Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure United States Influenza Medication Revenue  (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Influenza Medication Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Influenza Medication Sales Volume (K Pcs) Forecast by Type (2017-2022)
    Figure United States Influenza Medication Sales Volume (K Pcs) Forecast by Type (2017-2022)
    Figure United States Influenza Medication Sales Volume (K Pcs) Forecast by Type in 2022
    Table United States Influenza Medication Sales Volume (K Pcs) Forecast by Application (2017-2022)
    Figure United States Influenza Medication Sales Volume (K Pcs) Forecast by Application (2017-2022)
    Figure United States Influenza Medication Sales Volume (K Pcs) Forecast by Application in 2022
    Table United States Influenza Medication Sales Volume (K Pcs) Forecast by Region (2017-2022)
    Table United States Influenza Medication Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Influenza Medication Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Influenza Medication Sales Volume Share Forecast by Region in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy